Osiris Therapeutics designated as Orphan Drug title holder by EMA

RRY Publications to host a summit 8th Annual New York Stem Cell Summit '13 is being held in New York on February 19.

http://www.theflyonthewall.com/permalinks/entry.php/OSIRid1787937/OSIR-Osiris-Therapeutics-designated-as-Orphan-Drug-title-holder-by-EMA-